SCREEN-HFI (SCReening Evaluation of the Evolution of New Heart Failure Intervention Study)
Information source: Monash University
Information obtained from ClinicalTrials.gov on October 19, 2009 Link to the current ClinicalTrials.gov record.
Condition(s) targeted: Heart Failure
Intervention: Spironolactone (Drug); Placebo (Drug)
Phase: Phase 3
Status: Recruiting
Sponsored by: Monash University Official(s) and/or principal investigator(s): Henry Krum, MBBS FRACP PhD, Principal Investigator, Affiliation: Monash University / Alfred Hospital
Overall contact: Henry Krum, MBBS FRACP PhD, Phone: +61 3 9903 0042, Email: henry.krum@med.monash.edu.au
Summary
Individuals who were apart of the investigators Screen-HF study (NCT00400257) whose BNP
level are in the top quintile will be offered participation in this study. Participants
will be randomised to receive either spironolactone or placebo for two years. Participants
will then be monitored for indications of heart failure. It is anticipated that the
medication will reduce the development of heart failure in this group.
Clinical Details
Official title: SCREEN-HFI (SCReening Evaluation of the Evolution of New Heart Failure Intervention Study)
Study design: Prevention, Randomized, Double Blind (Subject, Investigator, Outcomes Assessor), Placebo Control, Parallel Assignment, Efficacy Study
Primary outcome: Effectiveness of Spironolactone in preventing heart failureCost effectiveness of Spironolactone prevention
Secondary outcome: Development of evidence of LV dysfunction, either systolic or diastolic, on echocardiography and/or symptomatic heart failureChange in 6 minute walk test between the two groups Change in quality of life between the two groups Change in left ventricular remodelling parameters
Eligibility
Minimum age: 60 Years.
Maximum age: N/A.
Gender(s): Both.
Criteria:
Inclusion Criteria:
1. Was recruited to SCREEN-HF
2. Has provided informed consent
Exclusion Criteria:
1. Uncorrected hyperkalaemia
2. eGFR < 30 ml/min
Locations and Contacts
Henry Krum, MBBS FRACP PhD, Phone: +61 3 9903 0042, Email: henry.krum@med.monash.edu.au
Alfred Hospital, Melbourne, Victoria 3004, Australia; Recruiting Henry Krum, MBBS FRACP PhD, Phone: +61 3 9903 0042, Email: henry.krum@med.monash.edu.au Henry Krum, MBBS FRACP PhD, Principal Investigator Chris Reid, A/Professor, Sub-Investigator Pupalan Iyngkaran, Doctor, Sub-Investigator Michele McGrady, Doctor, Sub-Investigator
Additional Information
Starting date: September 2008
Ending date: April 2010
Last updated: August 18, 2009
|